Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD.

N Engl J Med. 1998 Mar 26;338(13):853-60.

PMID:
9516219
[PubMed - indexed for MEDLINE]
Free Article
2.

Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.

Moorman AC, Von Bargen JC, Palella FJ, Holmberg SD.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):182-8.

PMID:
9768629
[PubMed - indexed for MEDLINE]
3.

Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators.

Holmberg SD, Moorman AC, Von Bargen JC, Palella FJ, Loveless MO, Ward DJ, Navin TR.

JAMA. 1998 Feb 4;279(5):384-6.

PMID:
9459473
[PubMed - indexed for MEDLINE]
4.

Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) Investigators.

Yangco BG, Von Bargen JC, Moorman AC, Holmberg SD.

Ann Intern Med. 2000 Feb 1;132(3):201-5.

PMID:
10651600
[PubMed - indexed for MEDLINE]
5.

Factors associated with the successful modification of antiretroviral therapy. HIV Outpatient Study Investigators.

Weidle PJ, Lichtenstein KA, Moorman AC, Von Bargen JC, Greenberg KS, Palella FJ Jr, Holmberg SD.

AIDS. 2000 Mar 31;14(5):491-7.

PMID:
10780711
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk